Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract

A Randomized, Placebo-Controlled, Single-Masked, Dose-Ranging Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataracts

This study will evaluate the safety and efficacy of three doses of C-KAD Ophthalmic Solution in patients with loss of visual function due to age-related nuclear cataract

Inclusion Criteria:

• Presence of nuclear sclerosis cataract
• BCDVA within the range of 20/40 and 20/80

Exclusion Criteria:

• Any other clinical condition in the eye that may compromise vision
• Presence or history of glaucoma
• Presence or history of diabetes
• Use of eyedrops
• Use of steroids